PMC:7029759 / 15359-15561 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PMC-OGER-BB

    {"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T285","span":{"begin":2,"end":12},"obj":"GO:0042571"},{"id":"T284","span":{"begin":107,"end":117},"obj":"GO:0042571"},{"id":"T283","span":{"begin":175,"end":183},"obj":"GO:0042571"}],"text":"t antibodies normally perform in the body 39. For the reasons mentioned above when discussing neutralizing antibodies, it will be difficult to validate a broadly neutralizing antibody quickly, and a cha"}

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T72","span":{"begin":37,"end":41},"obj":"Body_part"},{"id":"T73","span":{"begin":175,"end":183},"obj":"Body_part"}],"attributes":[{"id":"A72","pred":"fma_id","subj":"T72","obj":"http://purl.org/sig/ont/fma/fma256135"},{"id":"A73","pred":"fma_id","subj":"T73","obj":"http://purl.org/sig/ont/fma/fma62871"}],"text":"t antibodies normally perform in the body 39. For the reasons mentioned above when discussing neutralizing antibodies, it will be difficult to validate a broadly neutralizing antibody quickly, and a cha"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T127","span":{"begin":152,"end":153},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T128","span":{"begin":197,"end":198},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"t antibodies normally perform in the body 39. For the reasons mentioned above when discussing neutralizing antibodies, it will be difficult to validate a broadly neutralizing antibody quickly, and a cha"}